Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00280956
Status:
COMPLETED
Last Update Posted:
2016-06-16
First Post:
2006-01-21
Brief Title:
Open Label Natalizumab Safety Extension Study for Subjects With Crohns Disease
Sponsor:
Biogen
Organization:
Biogen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-07
Start Date Type:
None
Primary Completion Date:
2004-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-21
First Submit QC Date:
January 21 2006
Study First Post Date:
2006-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-14
Last Update Post Date:
2016-06-16
Last Update Post Date Type:
ESTIMATED